Literature DB >> 23073859

Whipple's disease.

Federico Biagi1, Lucia Trotta, Gino R Corazza.   

Abstract

Whipple's disease is a chronic multisystemic infection, due to Tropheryma whipplei, a bacterium ubiquitously present in the environment. Although it is very rare, its clinical features are non-specific and can affect several different districts. Whipple's disease is therefore a condition that should always be kept in mind by doctors working in several branches of medicine, such as internal medicine, gastroenterology, rheumatology, neurology, and cardiology. The condition is fatal if not promptly recognized and treated, but the best treatment is still not completely defined, especially in relapsing disease, neurological manifestations, and in cases of immunoreconstitution after initiation of antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23073859     DOI: 10.1007/s11739-012-0801-1

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  39 in total

1.  Tropheryma whipplei circulating in blood monocytes.

Authors:  D Raoult; H Lepidi; J R Harle
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

2.  A case of Whipple's disease (intestinal lipodystrophy).

Authors:  J W PAULLEY
Journal:  Gastroenterology       Date:  1952-09       Impact factor: 22.682

3.  High frequency of Tropheryma whipplei in culture-negative endocarditis.

Authors:  Walter Geissdörfer; Verena Moos; Annette Moter; Christoph Loddenkemper; Andreas Jansen; René Tandler; Andreas J Morguet; Florence Fenollar; Didier Raoult; Christian Bogdan; Thomas Schneider
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

4.  Relationship between previous treatments and onset of symptoms in patients with Whipple's disease.

Authors:  Lucia Trotta; Federico Biagi; Michele Di Stefano; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2012-06-14       Impact factor: 3.397

Review 5.  Whipple's disease.

Authors:  Florence Fenollar; Xavier Puéchal; Didier Raoult
Journal:  N Engl J Med       Date:  2007-01-04       Impact factor: 91.245

6.  Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease.

Authors:  Jean-Christophe Lagier; Florence Fenollar; Hubert Lepidi; Didier Raoult
Journal:  J Antimicrob Chemother       Date:  2011-03-08       Impact factor: 5.790

7.  Marginal and subgingival plaque--a natural habitat of Tropheryma whipplei?

Authors:  A S Zinkernagel; R Gmür; L Fenner; A Schaffner; G Schoedon; M Schneemann
Journal:  Infection       Date:  2003-03       Impact factor: 3.553

8.  Tropheryma whipplei bacteremia during fever in rural West Africa.

Authors:  Florence Fenollar; Oleg Mediannikov; Cristina Socolovschi; Hubert Bassene; Georges Diatta; Hervé Richet; Adama Tall; Cheikh Sokhna; Jean-François Trape; Didier Raoult
Journal:  Clin Infect Dis       Date:  2010-09-01       Impact factor: 9.079

9.  Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center.

Authors:  Jean-Christophe Lagier; Hubert Lepidi; Didier Raoult; Florence Fenollar
Journal:  Medicine (Baltimore)       Date:  2010-09       Impact factor: 1.889

10.  Genotyping reveals a wide heterogeneity of Tropheryma whipplei.

Authors:  Wenjun Li; Florence Fenollar; Jean-Marc Rolain; Pierre-Edouard Fournier; Gerhard E Feurle; Christian Müller; Verena Moos; Thomas Marth; Martin Altwegg; Romana C Calligaris-Maibach; Thomas Schneider; Federico Biagi; Bernard La Scola; Didier Raoult
Journal:  Microbiology       Date:  2008-02       Impact factor: 2.777

View more
  2 in total

Review 1.  Diarrhoea due to small bowel diseases.

Authors:  Joseph A Murray; Alberto Rubio-Tapia
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-10       Impact factor: 3.043

Review 2.  Whipple's Disease.

Authors:  Wilfried Obst; Ulrike von Arnim; Peter Malfertheiner
Journal:  Viszeralmedizin       Date:  2014-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.